Abstract:Dibenzo[a,c]cyclooctadiene lignans are natural products originated from Schisandra chinensis (Schisandraceae), a well-known medicinal plant in traditional Chinese medicine. The fruits and seeds have been used for centuries as a tonic and antitussive. Many studies have indicated that the active ingredients are lignans possessing an unusual structure derived from dibenzo[a,c]cyclooctadiene These lignans have been shown to possess a broad range of biological effects, including hepatoprotective and antiviral properties. Recently, dibenzocyclooctadiene lignans have been discussed as compounds that are able to overcome multidrug resistance. A panel of nine dibenzo[a,c]cyclooctadiene lignans (schizandrin, gomisin A, gomisin N, gomisin J, angeloylgomisin H, tigloylgomisin P, deoxyschizandrin, gammaschizandrin and wuweizisu C), isolated by us from seeds of S. chinensis, was examined for their effect on multidrug resistance, as well as their anti-proliferative and pro-apoptotic activities. CORL23/R, a multidrug resistant subline overexpressing multidrug resistanceassociated protein 1 (MRP1) together with its parent cell line CORL23 (human lung cell carcinoma) and HL60 (human promyelocytic leukemia) cell lines were used. We found that deoxyschizandrin and gammaschizandrin at relatively nontoxic concentrations restored the cytotoxic action of doxorubicin, a MRP1 substrate, to CORL23/R cells. Moreover, deoxyschizandrin and gammaschizandrin showed the greatest ability to enhance the accumulation of doxorubicin in drug resistant cells. Lignans alone had no effect on the cell cycle, however, in combination with subtoxic doses of doxorubicin, cell were arrested in the G2/M phase, which is typical for doxorubicin at toxic doses. Our results suggest that deoxyschizandrin and gammaschizandrin potentiate the effect of doxorubicin in doxorubicin resistant lung cancer cells by increasing the accumulation of doxorubicin inside the cells. The common structural feature of both active lignans and missing from the less active or inactive lignans is the Rbiaryl configuration and the absence of a hydroxy group at C8. Unlike the reversion effect, the cytotoxicity of lignans with either the Rbiaryl or Sbiaryl configurations was approximately same.

Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.

Dibenzocyclooctadiene Lingnans: a Class of Novel Inhibitors of P-glycoprotein

Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship

The effect of lignans from schisandra chinensis on drugresistance of lung cancer cells

Lignans from Schisandra chinensis restore the cytotoxic action of doxorubicin in drug resistant lung cancer cells

Natural Lignans from Arctium Lappa Modulate P-glycoprotein Efflux Function in Multidrug Resistant Cancer Cells

Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.

Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance

Design and Syntheses of Permethyl Ningalin B Analogues: Potent Multidrug Resistance (MDR) Reversal Agents of Cancer Cells

Schisandrin B--a novel inhibitor of P-glycoprotein.

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Neo-Clerodane Diterpenoids from Scutellaria Barbata Mediated Inhibition of P-glycoprotein in MCF-7/ADR Cells.

Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.

Sesquiterpene dimers with a rare skeleton from Chloranthus holostegius exhibiting multidrug resistance reversal activity in vitro and in vivo

Structure-activity relationship study of permethyl ningalin B analogues as P-glycoprotein chemosensitizers

Design, Synthesis and Biological Evaluation of Biaryl Amide Derivatives As Modulators of Multi-Drug Resistance

Synthesis, Pharmacological Activity of a Series of Genistein Derivatives as Modulators of Multidrug Resistance

Molecular Docking and Molecular Dynamics Studies Reveal the Anticancer Potential of Medicinal-Plant-Derived Lignans as MDM2-P53 Interaction Inhibitors

Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell

Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity

Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae